EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nu-Med Plus's enterprise value is $4.28 Mil.
Nu-Med Plus's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, Nu-Med Plus's EV-to-Revenue for today is .
The historical rank and industry rank for Nu-Med Plus's EV-to-Revenue or its related term are showing as below:
NUMD's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.065 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-06-09), Nu-Med Plus's stock price is $0.0501.
Nu-Med Plus's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Therefore, Nu-Med Plus's PS Ratio for today is .
Nu-Med Plus EV-to-Revenue Historical Data
The historical data trend for Nu-Med Plus's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nu-Med Plus's EV-to-Revenue
For the Medical Devices subindustry, Nu-Med Plus's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nu-Med Plus's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Nu-Med Plus's EV-to-Revenue falls into.
Nu-Med Plus's current Enterprise Value is $4.28 Mil.
Nu-Med Plus's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nu-Med Plus (OTCPK:NUMD) EV-to-Revenue Explanation
Nu-Med Plus's share price for today is $0.0501.
Nu-Med Plus's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nu-Med Plus EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Nu-Med Plus's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUMD has been successfully added to your 